{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:33Z","timestamp":1792097373326,"version":"4.4.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade Federal Da Fronteira Sul","id":[{"id":"https:\/\/ror.org\/03z9wm572","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cutaneous melanoma (CM) is the most aggressive form of skin cancer, characterized by high metastatic potential and resistance to conventional therapies. Evidence suggests that modulation of purinergic signaling, interleukin-6 (IL-6), and NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) may represent promising strategies for treating CM. Calcitriol, the active form of vitamin D, has demonstrated antineoplastic potential across different cancer types. In addition, reports have shown that purinergic signaling can be modulated by calcitriol. However, its mechanism of action on the purinergic system in melanoma remains poorly explored. In this study, we investigated the antineoplastic effects of calcitriol on human cutaneous malignant melanoma cell lines, with a focus on the purinergic system. The cells A375 and SK-MEL-28 were treated with calcitriol at 1, 10, and 50 nM for 24\u00a0h, and we analyzed cell viability, mitochondrial membrane potential, apoptotic body detection, migration, and ectonucleotidase enzymatic activity. We also analyzed the expression of ectonucleotidases (CD39 and CD73) and IL-6\/NLRP3. We found that calcitriol significantly reduced A375 cell viability, altered mitochondrial potential, inhibited cell migration, and induced the formation of apoptotic bodies. These effects were not observed in SK-MEL-28. Moreover, calcitriol modulated the ectonucleotidases activity and downregulated CD39 and CD73 expression. Additionally, the treatments downregulated IL-6 and NLRP3 expression. Thus, our findings demonstrate that calcitriol exerts antineoplastic effects on melanoma cells via mitochondrial dysfunction, apoptosis-related alterations, inhibition of migration, and modulation of purinergic and inflammatory mediators. Therefore, calcitriol is a promising adjuvant for CM therapy.<\/jats:p>","DOI":"10.1007\/s12032-026-03412-5","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:56:20Z","timestamp":1789451780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Calcitriol, the active form of vitamin D, induces cell death and purinergic signaling modulation in cutaneous melanoma cells"],"prefix":"10.1007","volume":"43","author":[{"given":"Gilnei Bruno","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Ant\u00f4nio","family":"Narzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Dallagnol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Cristina","family":"Ozelame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiane","family":"Manica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edtor Henrique Mendes","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniela Pinto","family":"Kempka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete Dulce","family":"Bagatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"3412_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.suc.2019.09.005","volume":"100","author":"S Carr","year":"2020","unstructured":"Carr S, Smith C, Wernberg J. Epidemiology and Risk Factors of Melanoma. Surg Clin North Am. 2020;100:1\u201312. https:\/\/doi.org\/10.1016\/j.suc.2019.09.005.","journal-title":"Surg Clin North Am"},{"key":"3412_CR2","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/genes12101543","volume":"12","author":"J Motwani","year":"2021","unstructured":"Motwani J, Eccles MR. Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis. Genes. 2021;12:1543. https:\/\/doi.org\/10.3390\/genes12101543.","journal-title":"Genes"},{"key":"3412_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1126\/science.1253735","volume":"346","author":"JA Lo","year":"2014","unstructured":"Lo JA, Fisher DE. The melanoma revolution: From UV carcinogenesis to a new era in therapeutics. Science. 2014;346:945\u20139. https:\/\/doi.org\/10.1126\/science.1253735.","journal-title":"Science"},{"key":"3412_CR4","unstructured":"IARC (International Agency for Research on Cancer). Cancer Incidence, Both sexes, in 2022, (2024). https:\/\/gco.iarc.fr\/today\/en\/dataviz\/tables?mode=cancer&group_populations=1&multiple_populations=1&types=0"},{"key":"3412_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41392-021-00827-6","volume":"6","author":"W Guo","year":"2021","unstructured":"Guo W, Wang H, Li C. Signal pathways of melanoma and targeted therapy, Signal Transduct. Target Ther. 2021;6:424. https:\/\/doi.org\/10.1038\/s41392-021-00827-6.","journal-title":"Target Ther"},{"key":"3412_CR6","doi-asserted-by":"crossref","unstructured":"Burnstock G. Purinergic signalling\u2013an overview, Novartis Found. Symp. 276 (2006) 26\u201348; discussion 48\u201357, 275\u2013281.","DOI":"10.1002\/9780470032244.ch4"},{"key":"3412_CR7","doi-asserted-by":"publisher","first-page":"239821281881749","DOI":"10.1177\/2398212818817494","volume":"2","author":"G Burnstock","year":"2018","unstructured":"Burnstock G. Purine and purinergic receptors, Brain Neurosci. Adv. 2018;2:2398212818817494. https:\/\/doi.org\/10.1177\/2398212818817494.","journal-title":"Adv"},{"key":"3412_CR8","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2741\/e298","volume":"E3","author":"G Burnstock","year":"2011","unstructured":"Burnstock G. Introductory overview of purinergic signalling. Front Biosci. 2011;E3:896\u2013900. https:\/\/doi.org\/10.2741\/e298.","journal-title":"Front Biosci"},{"key":"3412_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbagen.2004.09.006","volume":"1721","author":"DBR Leal","year":"2005","unstructured":"Leal DBR, Streher CA, Neu TN, Bittencourt FP, Leal CAM, Da Silva JEP, Morsch VM, Schetinger MRC. Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes. Biochim Biophys Acta BBA - Gen Subj. 2005;1721:9\u201315. https:\/\/doi.org\/10.1016\/j.bbagen.2004.09.006.","journal-title":"Biochim Biophys Acta BBA - Gen Subj"},{"key":"3412_CR10","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fphar.2019.00612","volume":"10","author":"MJ Hevia","year":"2019","unstructured":"Hevia MJ, Castro P, Pinto K, Reyna-Jeldes M, Rodr\u00edguez-Tirado F, Robles-Planells C, Ram\u00edrez-Rivera S, Madariaga JA, Gutierrez F, L\u00f3pez J, Barra M, De La Fuente-Ortega E, Bernal G, Coddou C. Differential Effects of Purinergic Signaling in Gastric Cancer-Derived Cells Through P2Y and P2X Receptors. Front Pharmacol. 2019;10:612. https:\/\/doi.org\/10.3389\/fphar.2019.00612.","journal-title":"Front Pharmacol"},{"key":"3412_CR11","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.3390\/cimb43030154","volume":"43","author":"MM Salahuddin","year":"2021","unstructured":"Salahuddin MM, Omran GA, Helmy MW, Houssen ME. Effect of Regorafenib on P2X7 Receptor Expression and Different Oncogenic Signaling Pathways in a Human Breast Cancer Cell Line: A Potential of New Insight of the Antitumor Effects of Regorafenib, Curr. Issues Mol Biol. 2021;43:2199\u2013209. https:\/\/doi.org\/10.3390\/cimb43030154.","journal-title":"Issues Mol Biol"},{"key":"3412_CR12","doi-asserted-by":"publisher","first-page":"11472","DOI":"10.3390\/ijms222111472","volume":"22","author":"C Dillard","year":"2021","unstructured":"Dillard C, Borde C, Mohammad A, Puchois V, Jourdren L, Larsen A, Sabbah M, Mar\u00e9chal V, Escargueil A, Pramil E. Expression Pattern of Purinergic Signaling Components in Colorectal Cancer Cells and Differential Cellular Outcomes Induced by Extracellular ATP and Adenosine. Int J Mol Sci. 2021;22:11472. https:\/\/doi.org\/10.3390\/ijms222111472.","journal-title":"Int J Mol Sci"},{"key":"3412_CR13","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.3390\/ijms26146890","volume":"26","author":"G Fistarol","year":"2025","unstructured":"Fistarol G, De Oliveira LA, Da Silva GB, Manica D, Hanauer MC, Dallagnol P, Narzetti RA, Bergamini ML, De Melo VC, Vidal T, Pillat MM, De Lima J, Da Cunha MLV, Makiyama ML, Marafon F, Kempka AP, Zamoner A, Bagatini MD. Dysregulation of Purinergic Signaling Sustains Chronic Inflammation and Oxidative Imbalance in Patients After PitNET Surgical Resection. Int J Mol Sci. 2025;26:6890. https:\/\/doi.org\/10.3390\/ijms26146890.","journal-title":"Int J Mol Sci"},{"key":"3412_CR14","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/15257770.2022.2032738","volume":"41","author":"O Harou","year":"2022","unstructured":"Harou O, Cros-Perrial E, Alix E, Callet-Bauchu E, Bertheau C, Dumontet C, Devouassoux-Shisheboran M, Jordheim LP. Variability in CD39 and CD73 protein levels in uveal melanoma patients. Nucleosides Nucleotides Nucleic Acids. 2022;41:1099\u2013108. https:\/\/doi.org\/10.1080\/15257770.2022.2032738.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"3412_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cellsig.2019.03.021","volume":"59","author":"A M\u00e2nica","year":"2019","unstructured":"M\u00e2nica A, Da Silva Rosa Bonadiman B, Cardoso AM, Paiz A, Siepko C, De Souza JVG, Moreno M, Moreno A, Schetinger MRC, Morsch VM, Bagatini MD. The signaling effects of ATP on melanoma-like skin cancer. Cell Signal. 2019;59:122\u201330. https:\/\/doi.org\/10.1016\/j.cellsig.2019.03.021.","journal-title":"Cell Signal"},{"key":"3412_CR16","doi-asserted-by":"publisher","first-page":"108647","DOI":"10.1016\/j.bioorg.2025.108647","volume":"163","author":"L Pham","year":"2025","unstructured":"Pham L, Chaudhary P, Han J, Yadav K, Ghimire K, Dahal S, Nguyen D, Kim B, Nguyen Y, Nguyen M, Kim EY, Kim H-R, Park HD, Lee SK, Kim J-A, Kim G. Development of 9-cinnamyl-9H-purine derivatives as potent anticancer agents through inactivation of NF-\u03bab\/p65 and p-STAT1 signaling pathways: Discovery of a new template for adenosine receptor. Bioorg Chem. 2025;163:108647. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108647.","journal-title":"Bioorg Chem"},{"key":"3412_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11302-024-10023-0","volume":"21","author":"D Manica","year":"2025","unstructured":"Manica D, Da Silva GB, Narzetti RA, Dallagnoll P, Da Silva AP, Marafon F, Cassol J, De Souza Matias L, Zamoner A, De Oliveira SFV, Maciel M, Moreno MD, Bagatini. Curcumin modulates purinergic signaling and inflammatory response in cutaneous metastatic melanoma cells. Purinergic Signal. 2025;21:277\u201388. https:\/\/doi.org\/10.1007\/s11302-024-10023-0.","journal-title":"Purinergic Signal"},{"key":"3412_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11302-024-10040-z","volume":"21","author":"GB Da Silva","year":"2025","unstructured":"Da Silva GB, Manica D, Dallagnol P, Narzetti RA, Marafon F, Da Silva AP, De L, Matias S, Cassol JV, Moreno M, Kempka AP, Bagatini MD. Rosmarinic acid modulates purinergic signaling and induces apoptosis in melanoma cells. Purinergic Signal. 2025;21:353\u201363. https:\/\/doi.org\/10.1007\/s11302-024-10040-z.","journal-title":"Purinergic Signal"},{"key":"3412_CR19","doi-asserted-by":"publisher","first-page":"9992","DOI":"10.1002\/jcb.28281","volume":"120","author":"MD Bagatini","year":"2019","unstructured":"Bagatini MD, Bertolin K, Bridi A, Pelinson LP, Da Silva Rosa B, Bonadiman MM, Pillat PBD, Gon\u00e7alves H, Ulrich MRC, Schetinger VM, Morsch. 1\u03b1, 25-Dihydroxyvitamin D3 alters ectonucleotidase expression and activity in human cutaneous melanoma cells. J Cell Biochem. 2019;120:9992\u201310000. https:\/\/doi.org\/10.1002\/jcb.28281.","journal-title":"J Cell Biochem"},{"key":"3412_CR20","doi-asserted-by":"publisher","first-page":"109333","DOI":"10.1016\/j.neuropharm.2022.109333","volume":"224","author":"F Di Virgilio","year":"2023","unstructured":"Di Virgilio F, Vultaggio-Poma V, Falzoni S, Giuliani AL, Extracellular ATP. A powerful inflammatory mediator in the central nervous system. Neuropharmacology. 2023;224:109333. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109333.","journal-title":"Neuropharmacology"},{"key":"3412_CR21","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.3390\/cells10081928","volume":"10","author":"L Magni","year":"2021","unstructured":"Magni L, Bouazzi R, Heredero Olmedilla H, Petersen PSS, Tozzi M, Novak I. The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells. Cells. 2021;10:1928. https:\/\/doi.org\/10.3390\/cells10081928.","journal-title":"Cells"},{"key":"3412_CR22","doi-asserted-by":"publisher","unstructured":"Gombault A, Baron L, Couillin I. ATP release and purinergic signaling in NLRP3 inflammasome activation. Front Immunol. 2013;3. https:\/\/doi.org\/10.3389\/fimmu.2012.00414.","DOI":"10.3389\/fimmu.2012.00414"},{"key":"3412_CR23","doi-asserted-by":"publisher","first-page":"L734","DOI":"10.1152\/ajplung.00389.2005","volume":"291","author":"CD Douillet","year":"2006","unstructured":"Douillet CD, Robinson WP, Milano PM, Boucher RC, Rich PB. Nucleotides induce IL-6 release from human airway epithelia via P2Y2 and p38 MAPK-dependent pathways. Am J Physiol -Lung Cell Mol Physiol. 2006;291:L734\u201346. https:\/\/doi.org\/10.1152\/ajplung.00389.2005.","journal-title":"Am J Physiol -Lung Cell Mol Physiol"},{"key":"3412_CR24","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1210\/en.2004-1527","volume":"146","author":"N Caraccio","year":"2005","unstructured":"Caraccio N, Monzani F, Santini E, Cuccato S, Ferrari D, Callegari MG, Gulinelli S, Pizzirani C, Di Virgilio F, Ferrannini E, Solini A. Extracellular Adenosine 5\u2032-Triphosphate Modulates Interleukin-6 Production by Human Thyrocytes through Functional Purinergic P2 Receptors. Endocrinology. 2005;146:3172\u20138. https:\/\/doi.org\/10.1210\/en.2004-1527.","journal-title":"Endocrinology"},{"key":"3412_CR25","doi-asserted-by":"publisher","first-page":"119037","DOI":"10.1016\/j.bbamcr.2021.119037","volume":"1868","author":"E Sano","year":"2021","unstructured":"Sano E, Kazaana A, Tadakuma H, Takei T, Yoshimura S, Hanashima Y, Ozawa Y, Yoshino A, Suzuki Y, Ueda T. Interleukin-6 sensitizes TNF-\u03b1 and TRAIL\/Apo2L dependent cell death through upregulation of death receptors in human cancer cells, Biochim. Biophys. Acta BBA - Mol. Cell Res. 2021;1868:119037. https:\/\/doi.org\/10.1016\/j.bbamcr.2021.119037.","journal-title":"Cell Res"},{"key":"3412_CR26","doi-asserted-by":"publisher","first-page":"27429","DOI":"10.1074\/jbc.M110.142752","volume":"285","author":"Y Liu","year":"2010","unstructured":"Liu Y, Li P-K, Li C, Lin J. Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells. J Biol Chem. 2010;285:27429\u201339. https:\/\/doi.org\/10.1074\/jbc.M110.142752.","journal-title":"J Biol Chem"},{"key":"3412_CR27","doi-asserted-by":"publisher","unstructured":"Sutedja EK, Amarassaphira D, Goenawan H, Susanti Pratiwi Y, Sylviana N, Setiabudiawan B, Suwarsa O, Tina Dewi R, Judistiani U, Supratman R, Lesmana. Calcitriol Inhibits Proliferation and Potentially Induces Apoptosis in B16-F10 Cells. Med Sci Monit Basic Res. 2022;28. https:\/\/doi.org\/10.12659\/MSMBR.935139.","DOI":"10.12659\/MSMBR.935139"},{"key":"3412_CR28","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/ph15091075","volume":"15","author":"FH Wong","year":"2022","unstructured":"Wong FH, Palanirajan VK, Ng ESC, Tan CK, Tan ESS, Amini F. Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple\u2013Negative Breast Cancer Cell Lines. Pharmaceuticals. 2022;15:1075. https:\/\/doi.org\/10.3390\/ph15091075.","journal-title":"Pharmaceuticals"},{"key":"3412_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s12672-011-0073-7","volume":"2","author":"S Swami","year":"2011","unstructured":"Swami S, Krishnan AV, Wang JY, Jensen K, Peng L, Albertelli MA, Feldman D. Inhibitory Effects of Calcitriol on the Growth of MCF-7 Breast Cancer Xenografts in Nude Mice: Selective Modulation of Aromatase Expression in vivo. Horm Cancer. 2011;2:190\u2013202. https:\/\/doi.org\/10.1007\/s12672-011-0073-7.","journal-title":"Horm Cancer"},{"key":"3412_CR30","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1007\/s10753-015-0209-y","volume":"38","author":"Y Hosokawa","year":"2015","unstructured":"Hosokawa Y, Hosokawa I, Shindo S, Ozaki K, Matsuo T. Calcitriol Suppressed Inflammatory Reactions in IL-1\u03b2-Stimulated Human Periodontal Ligament Cells. Inflammation. 2015;38:2252\u20138. https:\/\/doi.org\/10.1007\/s10753-015-0209-y.","journal-title":"Inflammation"},{"key":"3412_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cyto.2012.10.001","volume":"61","author":"N Noyola-Mart\u00ednez","year":"2013","unstructured":"Noyola-Mart\u00ednez N, D\u00edaz L, Avila E, Halhali A, Larrea F, Barrera D. Calcitriol downregulates TNF-\u03b1 and IL-6 expression in cultured placental cells from preeclamptic women. Cytokine. 2013;61:245\u201350. https:\/\/doi.org\/10.1016\/j.cyto.2012.10.001.","journal-title":"Cytokine"},{"key":"3412_CR32","unstructured":"CBRJ. Cell Bank of Rio de Janeiro (CBRJ), (n.d.). https:\/\/bcrj.org.br\/"},{"key":"3412_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4.","journal-title":"J Immunol Methods"},{"key":"3412_CR34","doi-asserted-by":"publisher","unstructured":"McGahon AJ, Martin SJ, Bissonnette RP, Mahboubi A, Shi Y, Mogil RJ, Nishioka WK, Green DR. Chap. 9 The End of the (Cell) Line: Methods for the Study of Apoptosis in Vitro, in: Methods Cell Biol., Elsevier, 1995: pp. 153\u2013185. https:\/\/doi.org\/10.1016\/S0091-679X(08)61929-9","DOI":"10.1016\/S0091-679X(08)61929-9"},{"key":"3412_CR35","doi-asserted-by":"publisher","unstructured":"Joshi DC, Bakowska JC. Determination of Mitochondrial Membrane Potential and Reactive Oxygen Species in Live Rat Cortical Neurons. J Vis Exp. 2011;2704. https:\/\/doi.org\/10.3791\/2704.","DOI":"10.3791\/2704"},{"key":"3412_CR36","doi-asserted-by":"publisher","first-page":"110427","DOI":"10.1016\/j.cbi.2023.110427","volume":"375","author":"GB Da Silva","year":"2023","unstructured":"Da Silva GB, Manica D, Da Silva AP, Marafon F, Moreno M, Bagatini MD. Rosmarinic acid decreases viability, inhibits migration and modulates expression of apoptosis-related CASP8\/CASP3\/NLRP3 genes in human metastatic melanoma cells. Chem Biol Interact. 2023;375:110427. https:\/\/doi.org\/10.1016\/j.cbi.2023.110427.","journal-title":"Chem Biol Interact"},{"key":"3412_CR37","doi-asserted-by":"publisher","unstructured":"Justus CR, Leffler N, Ruiz-Echevarria M, Yang LV. In vitro Cell Migration and Invasion Assays. J Vis Exp. 2014;51046. https:\/\/doi.org\/10.3791\/51046.","DOI":"10.3791\/51046"},{"key":"3412_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0049-3848(03)00178-6","volume":"109","author":"GI Lunkes","year":"2003","unstructured":"Lunkes GI, Lunkes D, Stefanello F, Morsch A, Morsch VM, Mazzanti CM, Schetinger MRC. Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res. 2003;109:189\u201394. https:\/\/doi.org\/10.1016\/S0049-3848(03)00178-6.","journal-title":"Thromb Res"},{"key":"3412_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/09537109609023582","volume":"7","author":"C Pilla","year":"1996","unstructured":"Pilla C, Emanuelli T, Frassetto SS, Battastini AMO, Dias RD, Sarkis JJF. ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets. Platelets. 1996;7:225\u201330. https:\/\/doi.org\/10.3109\/09537109609023582.","journal-title":"Platelets"},{"key":"3412_CR40","unstructured":"Giusti GB. G, In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. 1st edition. Weinheim, Germany: Verlag Chemie; 1984. pp. 315\u201323., in: Color. Method, n.d."},{"key":"3412_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u201354. https:\/\/doi.org\/10.1016\/0003-2697(76)90527-3.","journal-title":"Anal Biochem"},{"key":"3412_CR42","doi-asserted-by":"publisher","first-page":"886238","DOI":"10.3389\/fendo.2022.886238","volume":"13","author":"J Vanhevel","year":"2022","unstructured":"Vanhevel J, Verlinden L, Loopmans S, Doms S, Janssens I, Bevers S, Stegen S, Wildiers H, Verstuyf A. The Combination of the CDK4\/6 Inhibitor, Palbociclib, With the Vitamin D3 Analog, Inecalcitol, Has Potent In Vitro and In Vivo Anticancer Effects in Hormone-Sensitive Breast Cancer, But Has a More Limited Effect in Triple-Negative Breast Cancer. Front Endocrinol. 2022;13:886238. https:\/\/doi.org\/10.3389\/fendo.2022.886238.","journal-title":"Front Endocrinol"},{"key":"3412_CR43","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.1007\/s00432-022-04552-7","volume":"149","author":"J Yang","year":"2023","unstructured":"Yang J, Zhang Q, Huang G, Cong J, Wang T, Zhai X, Zhang J, Qi G, Zhou L, Jin J. Combined effects of vitamin D and neferine on the progression and metastasis of colorectal cancer. J Cancer Res Clin Oncol. 2023;149:6203\u201310. https:\/\/doi.org\/10.1007\/s00432-022-04552-7.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3412_CR44","doi-asserted-by":"publisher","unstructured":"Capobianco E, McGaughey V, Seraphin G, Heckel J, Rieger S, Lisse TS. Vitamin D inhibits osteosarcoma by reprogramming nonsense-mediated RNA decay and SNAI2-mediated epithelial-to-mesenchymal transition, (2023). https:\/\/doi.org\/10.1101\/2023.01.04.522778","DOI":"10.1101\/2023.01.04.522778"},{"key":"3412_CR45","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000512796","volume":"99","author":"A Casadei-Gardini","year":"2021","unstructured":"Casadei-Gardini A, Filippi R, Rimini M, Rapposelli IG, Fornaro L, Silvestris N, Aldrighetti L, Aimar G, Rovesti G, Bartolini G, Vivaldi C, Brunetti O, Sperti E, La Face R, Ratti F, Andrikou K, Valgiusti M, Bernardini L, Argentiero A, Fenocchio E, Frassineti GL, Cesario S, Giovannelli F, Quar\u00e0 V, Leone F, Cascinu S. Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients. Oncology. 2021;99:292\u20139. https:\/\/doi.org\/10.1159\/000512796.","journal-title":"Oncology"},{"key":"3412_CR46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/1568009621666210729100300","volume":"22","author":"S Yiyan","year":"2022","unstructured":"Yiyan S, Yang S, Li D, Li W. Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non-Small-Cell Lung Cancer Cells by Regulating the PI3K\/AKT\/mTOR SignalingPathway, Curr. Cancer Drug Targets. 2022;22:86\u201395. https:\/\/doi.org\/10.2174\/1568009621666210729100300.","journal-title":"Cancer Drug Targets"},{"key":"3412_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1515\/hmbci-2021-0031","volume":"43","author":"KA Aljunidee","year":"2022","unstructured":"Aljunidee KA, Bardaweel SK. Combination therapy of calcitriol inhibits the proliferation of breast cancer cells: new concept of nonclassical function of calcitriol. Horm Mol Biol Clin Investig. 2022;43:199\u2013205. https:\/\/doi.org\/10.1515\/hmbci-2021-0031.","journal-title":"Horm Mol Biol Clin Investig"},{"key":"3412_CR48","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jsbmb.2006.12.051","volume":"103","author":"AV Krishnan","year":"2007","unstructured":"Krishnan AV, Moreno J, Nonn L, Malloy P, Swami S, Peng L, Peehl DM, Feldman D. Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer. J Steroid Biochem Mol Biol. 2007;103:694\u2013702. https:\/\/doi.org\/10.1016\/j.jsbmb.2006.12.051.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3412_CR49","doi-asserted-by":"publisher","first-page":"10914","DOI":"10.3390\/ijms252010914","volume":"25","author":"P Dom\u017calski","year":"2024","unstructured":"Dom\u017calski P, Piotrowska A, Tuckey RC, Zmijewski MA. Anticancer Activity of Vitamin D, Lumisterol and Selected Derivatives against Human Malignant Melanoma Cell Lines. Int J Mol Sci. 2024;25:10914. https:\/\/doi.org\/10.3390\/ijms252010914.","journal-title":"Int J Mol Sci"},{"key":"3412_CR50","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3892\/ijo.2015.3088","volume":"47","author":"JM Wierzbicka","year":"2015","unstructured":"Wierzbicka JM, Binek A, Ahrends T, Ka JDN, Szyd\u0142owska A, Turczyk \u0141, W\u0105siewicz T, Wierzbicki PM, S\u0105dej R, Tuckey RC, Slominski AT, Chybicki J, Adrych K, Kmie\u0107 Z, \u017bmijewski MA. Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture. Int J Oncol. 2015;47:1084\u201396. https:\/\/doi.org\/10.3892\/ijo.2015.3088.","journal-title":"Int J Oncol"},{"key":"3412_CR51","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.3390\/ijms23052535","volume":"23","author":"J Schneider","year":"2022","unstructured":"Schneider J, Jeon YW, Suh YJ, Lim ST. Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast Cancer. Int J Mol Sci. 2022;23:2535. https:\/\/doi.org\/10.3390\/ijms23052535.","journal-title":"Int J Mol Sci"},{"key":"3412_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/jsre.1996.0092","volume":"61","author":"SRT Evans","year":"1996","unstructured":"Evans SRT, Houghton AM, Schumaker L, Brenner RV, Buras RR, Davoodi F, Nauta RJ, Shabahang M. Vitamin D Receptor and Growth Inhibition by 1,25-Dihydroxyvitamin D3in Human Malignant Melanoma Cell Lines. J Surg Res. 1996;61:127\u201333. https:\/\/doi.org\/10.1006\/jsre.1996.0092.","journal-title":"J Surg Res"},{"key":"3412_CR53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12929-023-00956-w","volume":"30","author":"S-F Wang","year":"2023","unstructured":"Wang S-F, Tseng L-M, Lee H-C. Role of mitochondrial alterations in human cancer progression and cancer immunity. J Biomed Sci. 2023;30:61. https:\/\/doi.org\/10.1186\/s12929-023-00956-w.","journal-title":"J Biomed Sci"},{"key":"3412_CR54","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1111\/bph.15801","volume":"179","author":"D Liu","year":"2022","unstructured":"Liu D, Rong H, Chen Y, Wang Q, Qian S, Ji Y, Yao W, Yin J, Gao X. Targeted disruption of mitochondria potently reverses multidrug resistance in cancer therapy. Br J Pharmacol. 2022;179:3346\u201362. https:\/\/doi.org\/10.1111\/bph.15801.","journal-title":"Br J Pharmacol"},{"key":"3412_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","volume":"15","author":"P Jin","year":"2022","unstructured":"Jin P, Jiang J, Zhou L, Huang Z, Nice EC, Huang C, Fu L. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol J Hematol Oncol. 2022;15:97. https:\/\/doi.org\/10.1186\/s13045-022-01313-4.","journal-title":"J Hematol Oncol J Hematol Oncol"},{"key":"3412_CR56","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/S0140-6736(11)61305-6","volume":"379","author":"AH Schapira","year":"2012","unstructured":"Schapira AH. Mitochondrial diseases. Lancet. 2012;379:1825\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(11)61305-6.","journal-title":"Lancet"},{"key":"3412_CR57","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","volume":"20","author":"A Moyer","year":"2025","unstructured":"Moyer A, Tanaka K, Cheng EH. Apoptosis in Cancer Biology and Therapy. Annu Rev Pathol Mech Dis. 2025;20:303\u201328. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-051222-115023.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"3412_CR58","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/ijms23031328","volume":"23","author":"O Morana","year":"2022","unstructured":"Morana O, Wood W, Gregory CD. The Apoptosis Paradox in Cancer. Int J Mol Sci. 2022;23:1328. https:\/\/doi.org\/10.3390\/ijms23031328.","journal-title":"Int J Mol Sci"},{"key":"3412_CR59","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/0885328219856248","volume":"34","author":"P Hu","year":"2019","unstructured":"Hu P, Fang D, Shen L, Zhou H, Shao R, Chen M, Yao C, Shi Y, Chen Q. Fibrin matrix containing high-dose calcitriol promotes the apoptosis of gastric cancer cells by sustainably releasing calcitrol and D-dimer. J Biomater Appl. 2019;34:509\u201322. https:\/\/doi.org\/10.1177\/0885328219856248.","journal-title":"J Biomater Appl"},{"key":"3412_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/647684","volume":"2012","author":"F Tas","year":"2012","unstructured":"Tas F. Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors. J Oncol. 2012;2012:1\u20139. https:\/\/doi.org\/10.1155\/2012\/647684.","journal-title":"J Oncol"},{"key":"3412_CR61","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1158\/2159-8290.CD-21-0010","volume":"11","author":"J Massagu\u00e9","year":"2021","unstructured":"Massagu\u00e9 J, Ganesh K, Cells M-I, Ecosystems. Cancer Discov. 2021;11:971\u201394. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0010.","journal-title":"Cancer Discov"},{"key":"3412_CR62","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.addr.2011.04.008","volume":"63","author":"TD Palmer","year":"2011","unstructured":"Palmer TD, Ashby WJ, Lewis JD, Zijlstra A. Targeting tumor cell motility to prevent metastasis. Adv Drug Deliv Rev. 2011;63:568\u201381. https:\/\/doi.org\/10.1016\/j.addr.2011.04.008.","journal-title":"Adv Drug Deliv Rev"},{"key":"3412_CR63","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited, Signal Transduct. Target Ther. 2020;5:28. https:\/\/doi.org\/10.1038\/s41392-020-0134-x.","journal-title":"Target Ther"},{"key":"3412_CR64","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11302-013-9372-5","volume":"9","author":"G Burnstock","year":"2013","unstructured":"Burnstock G, Di Virgilio F. Purinergic signalling and cancer. Purinergic Signal. 2013;9:491\u2013540. https:\/\/doi.org\/10.1007\/s11302-013-9372-5.","journal-title":"Purinergic Signal"},{"key":"3412_CR65","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.apsb.2023.12.004","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang L, Zhang J, Zhang W, Zheng M, Guo H, Pan X, Li W, Yang B, Ding L. The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies. Acta Pharm Sin B. 2024;14:1951\u201364. https:\/\/doi.org\/10.1016\/j.apsb.2023.12.004.","journal-title":"Acta Pharm Sin B"},{"key":"3412_CR66","doi-asserted-by":"publisher","first-page":"8871","DOI":"10.3390\/ijms24108871","volume":"24","author":"D Zahavi","year":"2023","unstructured":"Zahavi D, Hodge J. Targeting Immunosuppressive Adenosine Signaling: A Review of Potential Immunotherapy Combination Strategies. Int J Mol Sci. 2023;24:8871. https:\/\/doi.org\/10.3390\/ijms24108871.","journal-title":"Int J Mol Sci"},{"key":"3412_CR67","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","volume":"22","author":"C Xia","year":"2023","unstructured":"Xia C, Yin S, To KKW, Fu L. CD39\/CD73\/A2AR pathway and cancer immunotherapy. Mol Cancer. 2023;22:44. https:\/\/doi.org\/10.1186\/s12943-023-01733-x.","journal-title":"Mol Cancer"},{"key":"3412_CR68","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/biom12030418","volume":"12","author":"G Zhulai","year":"2022","unstructured":"Zhulai G, Oleinik E, Shibaev M, Ignatev K, Enzymes A-M. Adenosine Kinase and Adenosine Deaminase, in Cancer. Biomolecules. 2022;12:418. https:\/\/doi.org\/10.3390\/biom12030418.","journal-title":"Biomolecules"},{"key":"3412_CR69","doi-asserted-by":"publisher","unstructured":"Blackburn MR, Kellems RE. Adenosine Deaminase Deficiency: Metabolic Basis of Immune Deficiency and Pulmonary Inflammation, in: Adv. Immunol., Elsevier, 2005: pp. 1\u201341. https:\/\/doi.org\/10.1016\/S0065-2776(04)86001-2","DOI":"10.1016\/S0065-2776(04)86001-2"},{"key":"3412_CR70","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.pan.2021.03.018","volume":"21","author":"J Zhao","year":"2021","unstructured":"Zhao J, Soto LMS, Wang H, Katz MH, Prakash LR, Kim M, Tzeng C-WD, Lee JE, Wolff RA, Huang Y, Wistuba II, Maitra A, Wang H. Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival. Pancreatology. 2021;21:942\u20139. https:\/\/doi.org\/10.1016\/j.pan.2021.03.018.","journal-title":"Pancreatology"},{"key":"3412_CR71","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.3390\/cancers12103042","volume":"12","author":"YM Jeong","year":"2020","unstructured":"Jeong YM, Cho H, Kim T-M, Kim Y, Jeon S, Bychkov A, Jung CK. CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma. Cancers. 2020;12:3042. https:\/\/doi.org\/10.3390\/cancers12103042.","journal-title":"Cancers"},{"key":"3412_CR72","doi-asserted-by":"publisher","first-page":"26659","DOI":"10.18632\/oncotarget.25426","volume":"9","author":"I Monteiro","year":"2018","unstructured":"Monteiro I, Vigano S, Faouzi M, Treilleux I, Michielin O, M\u00e9n\u00e9trier-Caux C, Caux C, Romero P, De Leval L. CD73 expression and clinical significance in human metastatic melanoma. Oncotarget. 2018;9:26659\u201369. https:\/\/doi.org\/10.18632\/oncotarget.25426.","journal-title":"Oncotarget"},{"key":"3412_CR73","doi-asserted-by":"publisher","first-page":"119826","DOI":"10.1016\/j.lfs.2021.119826","volume":"282","author":"E Baghbani","year":"2021","unstructured":"Baghbani E, Noorolyai S, Shanehbandi D, Mokhtarzadeh A, Aghebati-Maleki L, Shahgoli VK, Brunetti O, Rahmani S, Shadbad MA, Baghbanzadeh A, Silvestris N, Baradaran B. Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints. Life Sci. 2021;282:119826. https:\/\/doi.org\/10.1016\/j.lfs.2021.119826.","journal-title":"Life Sci"},{"key":"3412_CR74","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12528","volume":"276","author":"B Allard","year":"2017","unstructured":"Allard B, Longhi MS, Robson SC, Stagg J. The ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets. Immunol Rev. 2017;276:121\u201344. https:\/\/doi.org\/10.1111\/imr.12528.","journal-title":"Immunol Rev"},{"key":"3412_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S. The P2X7 Receptor in Infection and Inflammation. Immunity. 2017;47:15\u201331. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.020.","journal-title":"Immunity"},{"key":"3412_CR76","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00418-016-1433-8","volume":"146","author":"NP Jobe","year":"2016","unstructured":"Jobe NP, R\u00f6sel D, Dvo\u0159\u00e1nkov\u00e1 B, Kodet O, Lacina L, Mateu R, Smetana K, Br\u00e1bek J. Simultaneous blocking of IL-6 and IL-8 is sufficient to fully inhibit CAF-induced human melanoma cell invasiveness. Histochem Cell Biol. 2016;146:205\u201317. https:\/\/doi.org\/10.1007\/s00418-016-1433-8.","journal-title":"Histochem Cell Biol"},{"key":"3412_CR77","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s10753-015-0186-1","volume":"38","author":"Q Tang","year":"2015","unstructured":"Tang Q, Jiang J, Liu J. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3. Inflammation. 2015;38:2049\u201356. https:\/\/doi.org\/10.1007\/s10753-015-0186-1.","journal-title":"Inflammation"},{"key":"3412_CR78","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/CMR.0b013e3283543d72","volume":"22","author":"L Hoejberg","year":"2012","unstructured":"Hoejberg L, Bastholt L, Schmidt H. Interleukin-6 and melanoma. Melanoma Res. 2012;22:327\u201333. https:\/\/doi.org\/10.1097\/CMR.0b013e3283543d72.","journal-title":"Melanoma Res"},{"key":"3412_CR79","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.beem.2011.05.001","volume":"25","author":"E Vanoirbeek","year":"2011","unstructured":"Vanoirbeek E, Krishnan A, Eelen G, Verlinden L, Bouillon R, Feldman D, Verstuyf A. The anti-cancer and anti-inflammatory actions of 1,25(OH)2D3, Best Pract. Res Clin Endocrinol Metab. 2011;25:593\u2013604. https:\/\/doi.org\/10.1016\/j.beem.2011.05.001.","journal-title":"Res Clin Endocrinol Metab"},{"key":"3412_CR80","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17:588\u2013606. https:\/\/doi.org\/10.1038\/nrd.2018.97.","journal-title":"Nat Rev Drug Discov"},{"key":"3412_CR81","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41419-018-0764-x","volume":"9","author":"F Lebreton","year":"2018","unstructured":"Lebreton F, Berishvili E, Parnaud G, Rouget C, Bosco D, Berney T, Lavallard V. NLRP3 inflammasome is expressed and regulated in human islets. Cell Death Dis. 2018;9:726. https:\/\/doi.org\/10.1038\/s41419-018-0764-x.","journal-title":"Cell Death Dis"},{"key":"3412_CR82","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-017-0553-x","volume":"36","author":"X Feng","year":"2017","unstructured":"Feng X, Luo Q, Zhang H, Wang H, Chen W, Meng G, Chen F. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma. J Exp Clin Cancer Res. 2017;36:81. https:\/\/doi.org\/10.1186\/s13046-017-0553-x.","journal-title":"J Exp Clin Cancer Res"},{"key":"3412_CR83","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.21037\/tcr-20-3135","volume":"10","author":"S Wu","year":"2021","unstructured":"Wu S, Zang Q, Dai B. The role of NLRP3 in the prognosis and immune infiltrates of skin cutaneous melanoma (SKCM), Transl. Cancer Res. 2021;10:1692\u2013702. https:\/\/doi.org\/10.21037\/tcr-20-3135.","journal-title":"Cancer Res"},{"key":"3412_CR84","doi-asserted-by":"publisher","first-page":"24271","DOI":"10.18632\/aging.203678","volume":"13","author":"Q Wang","year":"2021","unstructured":"Wang Q, Lyu J, Zhang W, Shi F, Ren Y, Mao Q, Liu Y, Li Y, Wang S. Immunological and clinical immunotherapy implications of NLRP3 mutations in melanoma. Aging. 2021;13:24271\u201389. https:\/\/doi.org\/10.18632\/aging.203678.","journal-title":"Aging"},{"key":"3412_CR85","doi-asserted-by":"publisher","first-page":"108545","DOI":"10.1016\/j.pharmthera.2023.108545","volume":"251","author":"IW Tengesdal","year":"2023","unstructured":"Tengesdal IW, Dinarello CA, Marchetti C. NLRP3 and cancer: Pathogenesis and therapeutic opportunities. Pharmacol Ther. 2023;251:108545. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108545.","journal-title":"Pharmacol Ther"},{"key":"3412_CR86","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4725","author":"A Piotrowska","year":"2019","unstructured":"Piotrowska A, Wierzbicka J, Rybarczyk A, Tuckey R, Slominski A, \u017bmijewski M. Vitamin D and its low calcemic analogs modulate the anticancer properties of cisplatin and dacarbazine in the human melanoma A375 cell line. Int J Oncol. 2019. https:\/\/doi.org\/10.3892\/ijo.2019.4725.","journal-title":"Int J Oncol"},{"key":"3412_CR87","doi-asserted-by":"publisher","first-page":"763895","DOI":"10.3389\/fonc.2021.763895","volume":"11","author":"A Piotrowska","year":"2021","unstructured":"Piotrowska A, Beserra FP, Wierzbicka JM, Nowak JI, \u017bmijewski MA. Vitamin D Enhances Anticancer Properties of Cediranib, a VEGFR Inhibitor, by Modulation of VEGFR2 Expression in Melanoma Cells. Front Oncol. 2021;11:763895. https:\/\/doi.org\/10.3389\/fonc.2021.763895.","journal-title":"Front Oncol"},{"key":"3412_CR88","doi-asserted-by":"publisher","first-page":"8037","DOI":"10.3390\/ijms24098037","volume":"24","author":"A Piotrowska","year":"2023","unstructured":"Piotrowska A, Zaucha R, Kr\u00f3l O, \u017bmijewski MA. Vitamin D Modulates the Response of Patient-Derived Metastatic Melanoma Cells to Anticancer Drugs. IJMS. 2023;24:8037. https:\/\/doi.org\/10.3390\/ijms24098037.","journal-title":"IJMS"},{"key":"3412_CR89","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/jpm4040448","volume":"4","author":"E Pettijohn","year":"2014","unstructured":"Pettijohn E, Martone B, Rademaker A, Kuzel T. A Phase I Study of High-Dose Calcitriol in Combination with Temozolomide for Patients with Metastatic Melanoma. JPM. 2014;4:448\u201358. https:\/\/doi.org\/10.3390\/jpm4040448.","journal-title":"JPM"},{"key":"3412_CR90","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.3390\/ijms19082236","volume":"19","author":"E Podgorska","year":"2018","unstructured":"Podgorska E, Drzal A, Matuszak Z, Swakon J, Slominski A, Elas M, Urbanska K. Calcitriol and Calcidiol Can Sensitize Melanoma Cells to Low\u2013LET Proton Beam Irradiation. IJMS. 2018;19:2236. https:\/\/doi.org\/10.3390\/ijms19082236.","journal-title":"IJMS"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03412-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03412-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03412-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:42:03Z","timestamp":1792096923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03412-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":90,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3412"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03412-5","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"288"}}